Answers are grounded in this paper and cite their sources.
The views expressed in this Guest Editorial do not necessarily reflect the views of this journal or of ASM. Malaria was estimated to result in 214 million clinical cases and 438,000 deaths in 2015, primarily in children under 5 years of age. In Africa, malaria causes approximately 10% of all deaths in children under 5 years of age. The RTS,S/AS01 malaria vaccine has been tested in young children in phase III clinical trials and shown to be 18 to 36% efficacious against clinical malaria (1). Although the vaccine may be efficacious against clinical malaria, it does not however reduce overall mortality. The World Health Organization (WHO) recently published a position paper on malaria vaccines (2), with emphasis on the RTS,S/AS01 vaccine. Although the vaccine has had modest efficacy, the data in Table 1 show that RTS,S was associated with higher all-cause mortality in girls (mortality ratio, 1.91; 95% confidence interval [CI], 1.30 to 2.79; P = 0.0006) …
No takes yet. Share an insight, caveat, or question.
Klein et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: